Clinical Trial Update: Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) [EARLY_Phase 1]

View source ↗

Summary

An early-phase study assessed adding atovaquone to conventional chemotherapy for newly diagnosed acute myeloid leukemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Atovaquone (Atovaquone)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Acute Myeloid Leukemia | EARLY_Phase 1 | Status: COMPLETED